Assessing risk: Data from montelukast clinical trials

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 4, 2009, Pages 697-698

  Kelsay, Kimberly ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

adverse experiences; allergic rhinitis; asthma; clinical trial; Montelukast; placebo; suicidality; suicide

Indexed keywords

MONTELUKAST; PLACEBO; ZAFIRLUKAST; ZILEUTON; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

AGGRESSION; AGITATION; ANXIETY; ASTHMA; ATOPY; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DESCRIPTIVE RESEARCH; DRUG INDUSTRY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HALLUCINATION; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; INSOMNIA; IRRITABILITY; MEDICAL DECISION MAKING; MENTAL HEALTH CARE; METHODOLOGY; PRIORITY JOURNAL; RESTLESSNESS; RISK ASSESSMENT; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; TREMOR; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; MENTAL DISEASE; NOTE; SUICIDE;

ACETATES; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; LEUKOTRIENE ANTAGONISTS; MENTAL DISORDERS; QUINOLINES; RISK ASSESSMENT; SUICIDE;

EID: 70449701583     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.09.001     Document Type: Editorial

References (7)

1. Leukotriene inhibitors: montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR). Healthcare Professional Sheet (2009), US Food and Drug Administration, Washington (DC)
2. Philip G., Hustad C., Noonan G., Malice M.-P., Ezekowitz A., Reiss T.F., et al. Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol 124 (2009) 691-696
3. Philip G., Hustad C.M., Malice M.-P., Noonan G., Ezekowitz A., Reiss T.F., et al. Analysis of behavior-related adverse experiences in clinical trials of montelukast. J Allergy Clin Immunol 124 (2009) 699-706
4. Posner K., Oquendo M., Gould M., Stanley B., and Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164 (2007) 989-991
5. Goodwin R., and Eaton W. Asthma, suicidal ideation, and suicide attempts: findings from the Baltimore epidemiological catchment area follow-up. Am J Public Health 95 (2005) 717-722
6. McQuaid E., Kopel S., and Nassau J. Behavioral adjustment in children with asthma. J Dev Behav Pediatr 22 (2001) 430-439
7. Nease D., and Maloin J. Depression screening: a practical strategy. J Fam Pract 52 (2003) 466-467